Search hospitals > Hawaii > Aiea
Hawaii Cancer Care - Savio
Claim this profileAiea, Hawaii 96701
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
111 reported clinical trials
14 medical researchers
Summary
Hawaii Cancer Care - Savio is a medical facility located in Aiea, Hawaii. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Hawaii Cancer Care - Savio is involved with conducting 111 clinical trials across 257 conditions. There are 14 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Michael Carney, MD, and Jami A. Fukui.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Jeffrey L. BerenbergStraub Clinic and Hospital7 years of reported clinical research
Expert in Lung Cancer
Expert in Cancer
28 reported clinical trials
75 drugs studied
Jared D. AcobaQueen's Medical Center4 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
15 reported clinical trials
35 drugs studied
Michael Carney, MDKapiolani Medical Center for Women and Children4 years of reported clinical research
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
14 reported clinical trials
29 drugs studied
Jami A. FukuiKapiolani Medical Center for Women and Children5 years of reported clinical research
Studies Breast Cancer
Studies Cancer
14 reported clinical trials
35 drugs studied
Clinical Trials running at Hawaii Cancer Care - Savio
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Diffuse Large B-Cell Lymphoma
Squamous Cell Carcinoma
Ovarian Cancer
Bladder Cancer
Small Cell Lung Cancer
Solid Tumors
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Hawaii Cancer Care - Savio?
Hawaii Cancer Care - Savio is a medical facility located in Aiea, Hawaii. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Hawaii Cancer Care - Savio is involved with conducting 111 clinical trials across 257 conditions. There are 14 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Michael Carney, MD, and Jami A. Fukui.